A Phase I Clinical Study of HLX316 in Participants With Advanced/Metastatic Solid Tumors
A Phase I Clinical Study of HLX316 in Participants With Advanced/Metastatic Solid Tumors
Recruiting · NCT07541534 · Registry updated 2026-05-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I Clinical Study of HLX316 in Participants With Advanced/Metastatic Solid Tumors | Advanced/Metastatic Solid Tumors | Recruiting | Phase 1 | 2026-05-28 | NCT07541534 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Henlius Biotech | 58 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| ChongQing Cancer Hospital | Chongqing | China | 14 |
| Hubei Cancer Hospital | Wuhan | China | 23 |
| Jinan Central Clinical College of Shandong First Medical University | Jinan | China | 1 |
| Obstetris &Gynecology Hospital of Fudan University | Shanghai | China | 1 |
| Shandong Cancer Hospital | Jinan | China | 19 |